White label ELPA - ClinicalTrials.eu

Study on Nepafenac and Dexamethasone for Reducing Inflammation and Swelling in Fuchs Dystrophy Patients After Corneal Transplant

Recruiting

3 1 1 1
Investigated Diseases:
- Corneal dystrophy
Investigated Drugs:
- Nepafenac
- Dexamethasone
Evaluation of inhaled formoterol fumarate to prevent lung complications after chest cancer surgery in high-risk patients

Recruiting

3 1 1 1
Investigated Diseases:
- Post procedural complication
Investigated Drugs:
- Formoterol Fumarate
Study on Personalized vs Non-Personalized Radionuclide Therapy with 177Lu-Edotreotide and Capecitabine for Patients with Neuroendocrine Tumors

Recruiting

3 1 1 1
Investigated Diseases:
- Neuroendocrine tumour
Investigated Drugs:
- Lutetium (177Lu) Edotreotide
- Capecitabine
Study of Pembrolizumab and Cabozantinib for Patients with Advanced Sarcomas: Undifferentiated Pleomorphic Sarcoma, Osteosarcoma, and Ewing Sarcoma

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Cabozantinib
- Pembrolizumab
Study on Anakinra for Treating Inflammatory Dilated Cardiomyopathy in Patients: Evaluating Efficacy and Safety of Anakinra with Standard Care vs. Standard Care Alone

Recruiting

2 1 1 1
Investigated Diseases:
- Dilated cardiomyopathy
Investigated Drugs:
- Anakinra
Study on the Effects of Lenomorelin in Patients with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy

Recruiting

2 1 1
Investigated Diseases:
- Ischaemic stroke
Investigated Drugs:
- Lenomorelin
Evaluation of personalized Iodine-131 therapy using PET imaging in patients with metastatic thyroid cancer

Recruiting

2 1 1 1
Investigated Drugs:
- Sodium Iodide (131I)
Study on the Safety and Efficacy of Avalglucosidase Alfa for Patients Aged 5 and Older with Non-Classic Pompe Disease

Recruiting

3 1 1 1
Investigated Diseases:
- Glycogen storage disease type II
Investigated Drugs:
- Avalglucosidase Alfa
Study on Decitabine, Venetoclax, and Tretinoin for Patients with Acute Myeloid Leukemia Who Cannot Have Induction Chemotherapy

Recruiting

3 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Tretinoin
- Placebo
Study on Durvalumab and Tremelimumab for Patients with Kidney Cancer at Risk of Recurrence After Surgery

Recruiting

3 1 1 1
Investigated Diseases:
- Renal cell carcinoma
Investigated Drugs:
- Durvalumab
- Tremelimumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies